Video Experimental Relacionado
Updated: Sep 10, 2025
06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
23.6K
Factores de riesgo para la hipertensión persistente en el aldosteronismo primario después de la cirugía: una revisión
1Department of Internal Medicine-Cardiovascular, Xiang'an Branch, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China.
Frontiers in physiology
|August 25, 2025
Resumen
Una mayor duración de la hipertensión, un IMC más alto, un nivel bajo de potasio y una reducción del eGFR predicen la hipertensión persistente después de la cirugía de aldosteronismo primario. La evaluación preoperatoria es clave para mejorar los resultados de los pacientes.
Área de la Ciencia:
- Endocrinología
- Nefrología
- Resultados de la cirugía
Sus antecedentes:
- El aldosteronismo primario (AP) es una causa común de hipertensión secundaria.
- El tratamiento quirúrgico de la PA tiene como objetivo la curación, pero la hipertensión persistente sigue siendo un desafío.
Objetivo del estudio:
- Para identificar los factores de riesgo de hipertensión persistente después de la cirugía en pacientes con PA.
- Informar sobre la estratificación del riesgo preoperatorio y la gestión postoperatoria.
Principales métodos:
- Revisión sistemática y metanálisis de 12 estudios.
- Busqué en las bases de datos de PubMed, Embase y Cochrane Library.
Principales resultados:
- Una mayor duración de la hipertensión antes de la cirugía es un predictor significativo.
- El índice de masa corporal (IMC) elevado aumenta el riesgo de hipertensión persistente.
- El bajo nivel de potasio sérico y la disminución de la tasa de filtración glomerular estimada (eGFR) están asociados con un mayor riesgo.
Conclusiones:
- La evaluación preoperatoria de la duración de la hipertensión, el IMC, los electrolitos y la función renal es crucial.
- Las estrategias de tratamiento postoperatorio adaptadas son esenciales para mejorar los resultados en pacientes con AP.
Palabras clave:
Cirugía de la adrenalectomíahipertensiónMetanálisisManejo postoperatorioaldosteronismo primario (PA)Más Videos Relacionados
Videos de Conceptos Relacionados
01:29Hypertension II: Pathophysiology
77
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
77
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
761
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
761
01:18Hypertension and Regulation of Blood Pressure
3.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.1K
01:33Hormonal Regulation
33.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.7K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
01:25Antihypertensive Drugs: Direct Renin Inhibitors
819
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
819